Segment and Geographic Information

3 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Segment and Geographic Information

Segment and Geographic Information

Our Chief Operating Decision Maker ("CODM") regularly reviews segment revenues and segment profits for performance evaluation and resources allocation. Segment revenues include certain acquisition-related adjustments for revenues that would otherwise have been recognized without the acquisition. Segment profits reflect controllable costs directly related to each segment and the allocation of certain corporate expenses such as corporate sales and marketing expenses and research and development project costs that benefit multiple segments. Certain items such as stock-based compensation, amortization of intangible assets, acquisition-related costs, net, restructuring and other charges, net, other expenses, net and certain unallocated corporate expenses are excluded from segment profits, which allow for more meaningful comparisons to the financial results of the historical operations for performance evaluation and resources allocation by our CODM.

•The Healthcare segment is primarily engaged in providing clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement.

•The Enterprise segment is primarily engaged in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web and messaging channels.

•The Other segment consists primarily of voicemail transcription services.

As more fully described in Note 4, on November 17, 2020, we entered into the Agreement to sell the Business, comprised of our medical transcription and EHR implementation businesses. Effective the first quarter of fiscal year 2021, the results of operations of the Business are included within discontinued operations for all periods presented. Our Healthcare segment revenue and segment profit for the historical periods have been recast to reflect the forementioned change.

We do not track our assets by segment. Consequently, it is not practical to show assets or depreciation by segment. The following table presents segment results along with a reconciliation of segment profit to (Loss) income before income taxes (dollars in thousands): 

	Three Months Ended December 31,
	2021		2020
Segment revenues:
Healthcare	$	200,400	$	199,332
Enterprise	117,227		139,152
Other	3,808		7,269
Total segment revenues	$	321,435	$	345,753
Segment profit:
Healthcare	$	43,139	$	74,812
Enterprise	18,725		41,468
Other	2,011		4,971
Total segment profit	$	63,875	$	121,251
Corporate expenses and other, net	(26,388)		(31,115)
Stock-based compensation	(38,399)		(34,906)
Amortization of intangible assets	(11,969)		(14,793)
Acquisition-related costs, net	(1,248)		(325)
Restructuring and other charges, net	(8,506)		(8,566)
Other expenses, net	(11,374)		(22,289)
(Loss) income before income taxes	$	(34,009)	$	9,257

No country outside of the United States provided greater than 10% of our total revenues. Revenues, classified by the major geographic areas in which our customers are located, were as follows (dollars in thousands): 

	Three Months Ended December 31,
	2021		2020
United States	$	259,776	$	272,598
International	61,659		73,155
Total revenues	$	321,435	$	345,753